Medivation Prostate Therapeutics LLC;The Regents of the University of Colorado, a body corporate
发明人:
COCHRANE, Dawn,RICHER, Jennifer,PROTTER, Andrew A.
申请号：
DK20120846720T
公开号：
DK2739153(T3)
申请日:
2012.07.27
申请国别(地区):
丹麦
年份:
2018
代理人:
摘要：
The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae I, II, III, IV, V, or VI for treating triple negative breast Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.
